ETS1 regulates the expression of ATXN2

Human Molecular Genetics

Volumn 21, Issue 23, 2012, Pages 5048-5065

  Scoles, Daniel R ^a   Pflieger, Lance T ^a   Thai, Khanh K ^a   Hansen, Stephen T ^a   Dansithong, Warunee ^a   Pulst, Stefan M ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; ATAXIA; ATXN2 GENE; AUTOSOMAL DOMINANT DISORDER; BINDING SITE; CAG REPEAT; CEREBELLUM; CHROMATIN IMMUNOPRECIPITATION; ENZYME ASSAY; GENE; GENE EXPRESSION; IN VIVO STUDY; OLFACTORY BULB; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SPINOCEREBELLAR ATAXIA TYPE 2; SPINOCEREBELLAR DEGENERATION; SPINOCEREBELLAR TRACT; START CODON; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; ANIMALS; BINDING SITES; CODON, INITIATOR; GENE EXPRESSION REGULATION; GENE ORDER; GENETIC VECTORS; HEK293 CELLS; HUMANS; LUCIFERASES; MICE; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEIN C-ETS-1; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEAT EXPANSION;

MUS MUSCULUS;

EID: 84869028505     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds349     Document Type: Article

References (49)

1. Pulst, S.M. (2003) Inherited ataxias: an introduction. In Pulst, S.M. (ed.), Genetics of Movement Disorders. Elsevier, Inc., Amsterdam, pp. 19-34.
2. Kim, J.M., Hong, S., Kim, G.P., Choi, Y.J., Kim, Y.K., Park, S.S., Kim, S.E. and Jeon, B.S. (2007) Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. Arch. Neurol., 64, 1510-1518.
3. Ross, O.A., Rutherford, N.J., Baker, M., Soto-Ortolaza, A.I., Carrasquillo, M.M., Dejesus-Hernandez, M., Adamson, J., Li, M., Volkening, K., Finger, E. et al. (2011) Ataxin-2 repeat-length variation and neurodegeneration. Hum. Mol. Genet., 20, 3207-3212.
4. Corrado, L., Mazzini, L., Oggioni, G.D., Luciano, B., Godi, M., Brusco, A. and D'Alfonso, S. (2011) ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum. Genet., 130, 575-580.
5. Elden, A.C., Kim, H.J., Hart, M.P., Chen-Plotkin, A.S., Johnson, B.S., Fang, X., Armakola, M., Geser, F., Greene, R., Lu, M.M. et al. (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature, 466, 1069-1075.
6. Van Damme, P., Veldink, J.H., van Blitterswijk, M., Corveleyn, A., van Vught, P.W., Thijs, V., Dubois, B., Matthijs, G., van den Berg, L.H. and Robberecht, W. (2011) Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology, 76, 2066-2072.
7. Lajoie, P. and Snapp, E.L. (2011) Formation and toxicity of soluble polyglutamine oligomers in living cells. PLoS One, 5, e15245.
8. Huynh, D.P., Del Bigio, M.R., Ho, D.H. and Pulst, S.M. (1999) Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2. Ann. Neurol., 45, 232-241.
9. Huynh, D.P., Yang, H.T., Vakharia, H., Nguyen, D. and Pulst, S.M. (2003) Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. Hum. Mol. Genet., 12, 1485-1496.
10. Duvick, L., Barnes, J., Ebner, B., Agrawal, S., Andresen, M., Lim, J., Giesler, G.J., Zoghbi, H.Y. and Orr, H.T. (2010) SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Neuron, 67, 929-935.
11. Yamanaka, T. and Nukina, N. (2010) Transcription factor sequestration by polyglutamine proteins. Methods Mol. Biol., 648, 215-229.
12. Koshy, B., Matilla, T., Burright, E.N., Merry, D.E., Fischbeck, K.H., Orr, H.T. and Zoghbi, H.Y. (1996) Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum. Mol. Genet., 5, 1311-1318.
13. Burke, J.R., Enghild, J.J., Martin, M.E., Jou, Y.S., Myers, R.M., Roses, A.D., Vance, J.M. and Strittmatter, W.J. (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat. Med., 2, 347-350.
14. Nonhoff, U., Ralser, M., Welzel, F., Piccini, I., Balzereit, D., Yaspo, M.L., Lehrach, H. and Krobitsch, S. (2007) Ataxin-2 interacts with the DEAD/ H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol. Biol. Cell, 18, 1385-1396.
15. Shibata, H., Huynh, D.P. and Pulst, S.M. (2000) A novel protein with RNA-binding motifs interacts with ataxin-2. Hum. Mol. Genet., 9, 1303-1313.
16. Ciosk, R., DePalma, M. and Priess, J.R. (2004) ATX-2, the C. elegans ortholog of ataxin 2, functions in translational regulation in the germline. Development, 131, 4831-4841.
17. Satterfield, T.F. and Pallanck, L.J. (2006) Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. Hum. Mol. Genet., 15, 2523-2532.
18. Nonis, D., Schmidt, M.H., van de Loo, S., Eich, F., Dikic, I., Nowock, J. and Auburger, G. (2008) Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cell Signal., 20, 1725-1739.
19. Liu, J., Tang, T.S., Tu, H., Nelson, O., Herndon, E., Huynh, D.P., Pulst, S.M. and Bezprozvanny, I. (2009) Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J. Neurosci., 29, 9148-9162.
20. Pulst, S.M., Santos, N., Wang, D., Yang, H., Huynh, D., Velazquez, L. and Figueroa, K.P. (2005) Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain, 128, 2297-2303.
21. Yamamoto, A., Lucas, J.J. and Hen, R. (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell, 101, 57-66.
22. Zu, T., Duvick, L.A., Kaytor, M.D., Berlinger, M.S., Zoghbi, H.Y., Clark, H.B. and Orr, H.T. (2004) Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. J. Neurosci., 24, 8853-8861.
23. Boy, J., Schmidt, T., Wolburg, H., Mack, A., Nuber, S., Bottcher, M., Schmitt, I., Holzmann, C., Zimmermann, F., Servadio, A. et al. (2009) Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3. Hum. Mol. Genet., 18, 4282-4295.
24. Alves, S., Nascimento-Ferreira, I., Dufour, N., Hassig, R., Auregan, G., Nobrega, C., Brouillet, E., Hantraye, P., Pedroso de Lima, M.C., Deglon, N. et al. (2010) Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3? Hum. Mol. Genet., 19, 2380-2394.
25. Kiehl, T.R., Nechiporuk, A., Figueroa, K.P., Keating, M.T., Huynh, D.P. and Pulst, S.M. (2006) Generation and characterization of Sca2 (ataxin-2) knockout mice. Biochem. Biophys. Res. Commun., 339, 17-24.
26. Aguiar, J., Santurlidis, S., Nowok, J., Alexander, C., Rudnicki, D., Gispert, S., Schulz, W. and Auburger, G. (1999) Identification of the physiological promoter for spinocerebellar ataxia 2 gene reveals a CpG island for promoter activity situated into the exon 1 of this gene and provides data about the origin of the nonmethylated state of these types of islands. Biochem. Biophys. Res. Commun., 254, 315-318.
27. Hallen, L., Klein, H., Stoschek, C., Wehrmeyer, S., Nonhoff, U., Ralser, M., Wilde, J., Rohr, C., Schweiger, M.R., Zatloukal, K. et al. (2011) The KRAB-containing zinc-finger transcriptional regulator ZBRK1 activates SCA2 gene transcription through direct interaction with its gene product, ataxin-2. Hum. Mol. Genet., 20, 104-114.
28. Hollenhorst, P.C., Shah, A.A., Hopkins, C. and Graves, B.J. (2007) Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes. Dev., 21, 1882-1894.
29. Crespo-Barreto, J., Fryer, J.D., Shaw, C.A., Orr, H.T. and Zoghbi, H.Y. (2010) Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis. PLoS Genet., 6, e1001021.
30. Allen Mouse Brain Atlas [Internet]. Allen Institute for Brain Science, Seattle, WA, 2009. http://mouse.brain-map.org.
31. Lein, E.S., Hawrylycz, M.J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A.F., Boguski, M.S., Brockway, K.S., Byrnes, E.J. et al. (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature, 445, 168-176.
32. Lastres-Becker, I., Brodesser, S., Lutjohann, D., Azizov, M., Buchmann, J., Hintermann, E., Sandhoff, K., Schurmann, A., Nowock, J. and Auburger, G. (2008) Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Hum. Mol. Genet., 17, 1465-1481.
33. McCann, C., Holohan, E.E., Das, S., Dervan, A., Larkin, A., Lee, J.A., Rodrigues, V., Parker, R. and Ramaswami, M. (2011) The Ataxin-2 protein is required for microRNA function and synapse-specific long-term olfactory habituation. Proc. Natl Acad. Sci. USA, 108, E655-E662.
34. Velazquez-Perez, L., Fernandez-Ruiz, J., Diaz, R., Gonzalez, R.P., Ochoa, N.C., Cruz, G.S., Mederos, L.E., Gongora, E.M., Hudson, R. and Drucker-Colin, R. (2006) Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases. J. Neurol., 253, 1165-1169.
35. Laffita-Mesa, J.M., Bauer, P.O., Kouri, V., Pena Serrano, L., Roskams, J., Almaguer Gotay, D., Montes Brown, J.C., Martinez Rodriguez, P.A., Gonzalez-Zaldivar, Y., Almaguer Mederos, L. et al. (2011) Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications. Hum. Genet., 131, 625-638.
36. Zu, T., Gibbens, B., Doty, N.S., Gomes-Pereira, M., Huguet, A., Stone, M.D., Margolis, J., Peterson, M., Markowski, T.W., Ingram, M.A. et al. (2011) Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl Acad. Sci. USA, 108, 260-265.
37. Broda, M., Kierzek, E., Gdaniec, Z., Kulinski, T. and Kierzek, R. (2005) Thermodynamic stability of RNA structures formed by CNG trinucleotide repeats. Implication for prediction of RNA structure. Biochemistry, 44, 10873-10882.
38. Dansithong, W., Wolf, C.M., Sarkar, P., Paul, S., Chiang, A., Holt, I., Morris, G.E., Branco, D., Sherwood, M.C., Comai, L. et al. (2008) Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features. PLoS One, 3, e3968.
39. Sobczak, K. and Krzyzosiak, W.J. (2005) CAG repeats containing CAA interruptions form branched hairpin structures in spinocerebellar ataxia type 2 transcripts. J. Biol. Chem., 280, 3898-3910.
40. Gerhauser, I., Alldinger, S., Ulrich, R. and Baumgartner, W. (2005) Spatio-temporal expression of immediate early genes in the central nervous system of SJL/J mice. Int. J. Dev. Neurosci., 23, 637-649.
41. Miyake, T., Aoki, M., Osako, M.K., Shimamura, M., Nakagami, H. and Morishita, R. (2011) Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor kappaB and ets prevents abdominal aortic aneurysm in rat model. Mol. Ther., 19, 181-187.
42. Souissi, I., Najjar, I., Ah-Koon, L., Schischmanoff, P.O., Lesage, D., Le Coquil, S., Roger, C., Dusanter-Fourt, I., Varin-Blank, N., Cao, A. et al. (2011) A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-kappaB. BMC Cell Biol., 12, 14.
43. Alexander, J.H., Hafley, G., Harrington, R.A., Peterson, E.D., Ferguson, T.B. Jr, Lorenz, T.J., Goyal, A., Gibson, M., Mack, M.J., Gennevois, D. et al. (2005) Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA, 294, 2446-2454.
44. Ng, H., Pulst, S.M. and Huynh, D.P. (2007) Ataxin-2 mediated cell death is dependent on domains downstream of the polyQ repeat. Exp. Neurol., 208, 207-215.
45. Huynh, D.P., Figueroa, K., Hoang, N. and Pulst, S.M. (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat. Genet., 26, 44-50.
46. Holterman, C.E., Franovic, A., Payette, J. and Lee, S. (2010) ETS-1 oncogenic activity mediated by transforming growth factor alpha. Cancer Res., 70, 730-740.
47. Quandt, K., Frech, K., Karas, H., Wingender, E. and Werner, T. (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res., 23, 4878-4884.
48. Schug, J. (2008) Using TESS to predict transcription factor binding sites in DNA sequence. Curr. Protoc. Bioinformatics., Chapter 2, Unit 2.6.
49. Hollenhorst, P.C., Chandler, K.J., Poulsen, R.L., Johnson, W.E., Speck, N.A. and Graves, B.J. (2009) DNA specificity determinants associate with distinct transcription factor functions. PLoS Genet., 5, e1000778.